Pacific Biosciences of California, Inc.
(NASDAQ : PACB)

( )
PACB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.31%186.671.1%$893.59m
GILDGilead Sciences, Inc.
1.90%80.910.9%$837.97m
CELGCelgene Corporation
1.95%95.611.2%$687.44m
BIIBBiogen Inc.
2.80%292.781.2%$564.73m
JUNOJuno Therapeutics, Inc.
0.02%86.5813.5%$436.33m
REGNRegeneron Pharmaceuticals, Inc.
2.55%323.862.7%$403.87m
VRTXVertex Pharmaceuticals Incorporated
5.27%165.901.9%$348.24m
ALXNAlexion Pharmaceuticals, Inc.
3.79%118.932.0%$257.26m
NKTRNektar Therapeutics
1.58%89.606.0%$256.22m
ILMNIllumina, Inc.
3.13%233.843.5%$231.09m
AAgilent Technologies, Inc.
0.03%70.701.5%$186.84m
BLUEBluebird Bio, Inc.
2.41%206.0516.1%$156.27m
INCYIncyte Corporation
3.06%87.802.5%$152.45m
EXASExact Sciences Corporation
-5.82%42.3726.0%$117.22m
BMRNBioMarin Pharmaceutical Inc.
-1.13%83.054.4%$116.68m

Company Profile

Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia. It offers deoxyribonucleic acid sequencing, third generation sequencing instrument, compatible workflow and analysis, resequencing and variant detection, epigenetics, multiplexing, sample and template preparation kits, binding kits, and sequel software applications. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.